Global Medical REIT (NYSE: GMRE)
$7.36
(-0.3%)
-$0.02
Price as of April 16, 2025, 3:58 p.m. ET
GMRE
Key Data Points
Current Price
$7.37
Daily Change
(-0.3%) -$0.03
Day's Range
$7.32 - $7.49
Previous Close
$7.35
Open
$7.41
Beta
0.93
Volume
35
Average Volume
519,049
Sector
Market Cap
$492M
Market Cap / Employee
$19M
52wk Range
$6.75 - $10.46
Revenue
$156M
Gross Margin
45.75%
Dividend Yield
11.4%
EPS
$0.01
CAPs Rating
-
Industry
Equity Real Estate Investment Trusts (REITs)
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
Global Medical REIT Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Global Medical REIT Company Info
Global Medical REIT, Inc. engages in the acquisition of purpose-built healthcare facilities and the leasing of those properties to healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.
News & Analysis
Featured Article
2 High-Yielding Dividend Stocks Worth the Risk and 1 That Isn't
Not all medical REITs are created equal.
Jim Halley | Oct 20, 2022
Featured Article
3 Unknown but Amazing Dividend Stocks
Profit by seeking cash flow where few others look.
Will Healy | Nov 22, 2020
3 Elite Medical REITs That Look Like Great Buys Now
Jim Halley | Sep 22, 2020
The decline in elective procedures has lowered the share prices of REITs that specialize in medical office space.
3 Stocks to Buy With Dividends Yielding More Than 6%
David Jagielski | Mar 22, 2020
It's a great time to go bargain-hunting for dividend stocks.
Financial Health
General
Q4 2024 | YoY Change |
---|
Revenue Growth Rate
Earnings Per Share Growth Rate
Assets
Q4 2024 | YoY Change |
---|
Liabilities
Q4 2024 | YoY Change |
---|
Ratios
Q4 2024 | YoY Change |
---|
Cash Flow
Q4 2024 | YoY Change |
---|
Valuation
Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | YoY Change |
---|
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.